Atenolol reduces cardiac-mediated mortality in a genetic mouse model of sudden unexpected death in epilepsy
Soh, M. S.; Kuanyshbek, A.; Mohamed Syazwan, E. S.; Lee, H. M.; McKenzie, C. E.; Phillips, A. M.; Hu, A.; Scheffer, I. E.; Semsarian, C.; Berkovic, S. F.; Reid, C. A.
Show abstract
Sudden Unexpected Death in Epilepsy (SUDEP) is the leading cause of premature mortality in epilepsy. Genetic cardiac risk factors, including loss-of-function KCNH2 variants, have been linked to SUDEP. We hypothesised that seizures and LQTS interact to increase SUDEP risk. To investigate this, we crossed Kcnh2+/- and Gabrg2R43Q/+ mice that model LQTS and genetic epilepsy, respectively. Electrocorticography and electrocardiogram confirmed that Kcnh2+/- mice had a LQTS phenotype, while Gabrg2R43Q/+ mice displayed spontaneous seizures. Double mutant mice (Gabrg2R43Q/+/Kcnh2+/-) had both seizure and LQTS phenotypes that were indistinguishable from the respective single mutant mice. Survival analysis revealed that Gabrg2R43Q/+/Kcnh2+/- mice experienced a disproportionate higher rate of seizure-related death. Long-term oral administration of atenolol, a cardiac-selective {beta}-blocker, significantly improved survival in the Gabrg2R43Q/+/Kcnh2+/- mice. An additional mouse model, Hcn1M294L/+/Kcnh2+/-, based on a HCN1 developmental epileptic encephalopathy variant, also experienced a disproportionately higher rate of premature death that was rescued by atenolol. Kcnh2+/- mice also spent more time in ventricular arrhythmia during proconvulsant-induced seizures. Overall, the data implicates cardiac and loss-of-function KCNH2 variants as an important risk factor, and the potential repurposing of {beta}- blockers as a prevention strategy, for SUDEP in a subset of epilepsy patients.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Development of an Antiseizure Drug Screening Platform for Dravet Syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program 96%
- Systemic administration of Ivabradine, an HCN channel inhibitor, blocks spontaneous absence seizures 96%
- Daily intermittent fasting is an effective multiscale treatment in preclinical models of absence epilepsy 95%
Similar papers in this journal
- New Insights into Epileptic Spasm Generation and Treatment from the TTX Animal Model 95%
- Clemizole and Trazodone are Effective Antiseizure Treatments in a Zebrafish Model of STXBP1 Disorder 94%
- Gene panels for epilepsy suggest that previously defined variants of unknown significance may play an important role in epilepsy and certain variants may be pathogenic when occurring together 94%
Similar papers in this journal
- Excitation/Inhibition balance relates to cognitive function and gene expression in Temporal Lobe Epilepsy: an hdEEG assessment with aperiodic exponent 93%
- Low frequency interictal EEG biomarker for localizing seizures 93%
- Graph Theoretical Measures of Fast Ripples Support the Epileptic Network Hypothesis 93%
Similar papers in this journal
- Neurodevelopmental defects in Dravet syndrome Scn1a+/- mice: targeting GABA-switch rescues behavioral dysfunctions but not seizures and mortality. 95%
- Novel Mouse Model of Alternating Hemiplegia of Childhood Exhibits Prominent Motor and Seizure Phenotypes 95%
- Human and Rodent Seizures Demonstrate a Dynamic Interplay with Spreading Depolarizations 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.